[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2008105326A1 - ２－イミノ－４－チアゾリジノン誘導体及び２，４－チアゾリジンジオン誘導体の製造方法 - Google Patents

２－イミノ－４－チアゾリジノン誘導体及び２，４－チアゾリジンジオン誘導体の製造方法 Download PDF

Info

Publication number
WO2008105326A1
WO2008105326A1 PCT/JP2008/053018 JP2008053018W WO2008105326A1 WO 2008105326 A1 WO2008105326 A1 WO 2008105326A1 JP 2008053018 W JP2008053018 W JP 2008053018W WO 2008105326 A1 WO2008105326 A1 WO 2008105326A1
Authority
WO
WIPO (PCT)
Prior art keywords
imino
derivative
thiazolidinone
pyridyl
ethoxy
Prior art date
Application number
PCT/JP2008/053018
Other languages
English (en)
French (fr)
Inventor
Hiroshi Shimamura
Original Assignee
Ohara Chemical Industries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ohara Chemical Industries, Ltd. filed Critical Ohara Chemical Industries, Ltd.
Publication of WO2008105326A1 publication Critical patent/WO2008105326A1/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

【課題】５－｛４－［２－（５－エチル－２－ピリジル）エトキシ］ベンジル｝－２，４－チアゾリジンジオン（一般名：ピオグリタゾン）を、工程数が少なく、かつ高収率で得ることができる製造方法を提供すること。 【解決手段】４－［２－（５－エチル－２－ピリジル）エトキシ］ベンズアルデヒドと２－イミノ－４－チアゾリジノンとを縮合反応させて、中間体として新規化合物の５－｛４－［２－（５－エチル－２－ピリジル）エトキシ］ベンジリデン｝－２－イミノ－４－チアゾリジノンを得、この新規化合物を還元して、５－｛４－［２－（５－エチル－２－ピリジル）エトキシ］ベンジル｝－２－イミノ－４－チアゾリジノンとし、これを加水分解することにより、５－｛４－［２－（５－エチル－２－ピリジル）エトキシ］ベンジル｝－２，４－チアゾリジンジオンを得る。
PCT/JP2008/053018 2007-02-28 2008-02-22 ２－イミノ－４－チアゾリジノン誘導体及び２，４－チアゾリジンジオン誘導体の製造方法 WO2008105326A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007049241 2007-02-28
JP2007-049241 2007-02-28

Publications (1)

Publication Number Publication Date
WO2008105326A1 true WO2008105326A1 (ja) 2008-09-04

Family

ID=39721161

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/053018 WO2008105326A1 (ja) 2007-02-28 2008-02-22 ２－イミノ－４－チアゾリジノン誘導体及び２，４－チアゾリジンジオン誘導体の製造方法

Country Status (1)

Country Link
WO (1) WO2008105326A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010208957A (ja) * 2009-03-06 2010-09-24 Tokuyama Corp 結晶構造を有する５−｛４−［２−（５−エチル−２−ピリジル）エトキシ］ベンジル｝−２−イミノ−４−チアゾリジノン及びその製造方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61267580A (ja) * 1985-01-19 1986-11-27 Takeda Chem Ind Ltd チアゾリジン誘導体
JPH1072438A (ja) * 1996-06-27 1998-03-17 Takeda Chem Ind Ltd ベンズアルデヒド化合物の製造法
WO2006019741A1 (en) * 2004-07-14 2006-02-23 Janssen Pharmaceutica N.V. Arylidenes for the treatment of estrogen related receptor-alpha mediated diseases

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61267580A (ja) * 1985-01-19 1986-11-27 Takeda Chem Ind Ltd チアゾリジン誘導体
JPH1072438A (ja) * 1996-06-27 1998-03-17 Takeda Chem Ind Ltd ベンズアルデヒド化合物の製造法
WO2006019741A1 (en) * 2004-07-14 2006-02-23 Janssen Pharmaceutica N.V. Arylidenes for the treatment of estrogen related receptor-alpha mediated diseases

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DING Y. ET AL.: "Synthesis of thiazolone-based sulfonamides as inhibitors of HCV NS5B polymerase", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 17, no. 3, 1 February 2007 (2007-02-01), pages 841 - 845, XP005835951 *
HU B. ET AL.: "New oxadiazolidinedione derivatives as potent and selective human beta3 agonists", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 11, no. 8, 2001, pages 981 - 984, XP002275761 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010208957A (ja) * 2009-03-06 2010-09-24 Tokuyama Corp 結晶構造を有する５−｛４−［２−（５−エチル−２−ピリジル）エトキシ］ベンジル｝−２−イミノ−４−チアゾリジノン及びその製造方法

Similar Documents

Publication Publication Date Title
WO2005080358A3 (en) Rosiglitazone phosphate and polymorphic forms
WO2008104847A3 (en) Processes for the preparation of pramipexole and salts thereof
IL223002A0 (en) Crystalline form of 4- [5 - [3 -chloro-5 - (trifluoromethyl) phenyl] -4, 5 - dihydro - 5 - (trifluoromethyl) -3 - isoxazolyl] -n- [2-0x0-2- [ ( 2, 2, 2 - trifluoroethyl) amino] ethyl] -1- naphthalenecarboxamide
WO2008062376A3 (en) New process for the preparation of 2-imino-thiazolidin-4-one derivatives
NZ594267A (en) Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof
WO2008034638A3 (de) Verfahren zur metallisierung von halbleiterbauelementen und verwendung
WO2008130312A8 (en) A new process for the manufacturing of the compound 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1h-indole-5-carbonitrile 701
WO2009102155A3 (en) Process for preparation of 2-methyl-2´-phenylpropionic acid derivatives and novel intermediate compounds
IL207854A0 (en) Crystal forms of 5-[3-(2,5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4]oxadiazol-5-yl]-3-nit robenzene-1,2-diol
WO2011021214A3 (en) Improved process for preparing (s)-2-amino-4, 5, 6, 7-tetrahydro-6-(propylamino)benzothiazole and its dhtydrochloride monohydrate
WO2007030385A3 (en) A process for preparing oxazolidine protected aminodiol compounds useful as intermediates to florfenicol
WO2008023027A3 (en) Process for preparing pramipexole dihydrochloride tablets with high storage stability
UA92354C2 (en) Amino acid salts of rosiglitazone
MX2009006636A (es) Nuevos intermediarios y procesos utiles en la rpeparacion de {2-[1-(3,5-bis-trifluorometil-bencil)-5-piridin-4-il-1h-[1,2,3]tr iazol-4-il]-piridin-3-il}-(2-clorofenil)-metanona.
WO2008045777A3 (en) A process for the preparation of benzimidazole derivatives and their salts
WO2009021749A8 (en) Preparation of a compound for the treatment of duchenne muscular dystrophy
WO2007106022A3 (en) A new crystalline form g of (5s) -5- [4- (5-chloro-pyridin-2- yloxy) -piperidine-1-sulfonylmethyl] - 5 -methyl -imidazolidine - 2,4-dione (i) and intermediates thereof.
BRPI0517396A (pt) preparação oral com melhor biodisponibilidade
WO2008105326A1 (ja) ２－イミノ－４－チアゾリジノン誘導体及び２，４－チアゾリジンジオン誘導体の製造方法
YU40202A (sh) Novi derivati tiazolidindiona kao antidijabetički agensi
WO2009149053A3 (en) Naproxcinod process and solid dispersion
WO2006081807A3 (de) Verfahren zur herstellung von losartan
PE20010047A1 (es) Monohidrato de hidrocloruro de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidina-2,4-diona
WO2010049952A3 (en) A novel process for the preparation of eletriptan
WO2008010089A3 (en) Process for preparation of intermediates of rosiglitazone, rosiglitazone and polymorphic forms thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08711792

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08711792

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP